000 01375 a2200397 4500
005 20250516015945.0
264 0 _c20110714
008 201107s 0 0 eng d
022 _a1029-2403
024 7 _a10.3109/10428194.2010.543713
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVos, Josephine M I
245 0 0 _aWaxing and waning intravascular large cell lymphoma with widespread organ infiltration.
_h[electronic resource]
260 _bLeukemia & lymphoma
_cApr 2011
300 _a705-8 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xadverse effects
650 0 4 _aAntigens, CD20
_ximmunology
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aBlood Vessels
_xpathology
650 0 4 _aBone Marrow
_xpathology
650 0 4 _aFatal Outcome
650 0 4 _aHumans
650 0 4 _aKidney
_xpathology
650 0 4 _aLymphoma, Large B-Cell, Diffuse
_xdrug therapy
650 0 4 _aMale
650 0 4 _aRituximab
700 1 _aBordbar, Arash
700 1 _aVet, Ramon J
700 1 _aPals, Steven T
700 1 _aKater, Arnon P
773 0 _tLeukemia & lymphoma
_gvol. 52
_gno. 4
_gp. 705-8
856 4 0 _uhttps://doi.org/10.3109/10428194.2010.543713
_zAvailable from publisher's website
999 _c20477245
_d20477245